This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n7http://localhost/temp/predkladatel/
n13http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n18http://linked.opendata.cz/ontology/domain/vavai/
n6http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
n14http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14110%2F10%3A00047011%21RIV11-MSM-14110___/
skoshttp://www.w3.org/2004/02/skos/core#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14110%2F10%3A00047011%21RIV11-MSM-14110___
rdf:type
skos:Concept n18:Vysledek
dcterms:description
The efficacy of dopamine (DA) agonists in the treatment of motor symptoms of Parkinsons disease (PD) has been clearly demonstrated. It has also been documented that DA agonists may have both a positive and a negative impact on neuropsychiatric symptoms in PD patients. This paper will focus on the effects of DA agonists on depressive and cognitive symptoms of PD. The efficacy of dopamine (DA) agonists in the treatment of motor symptoms of Parkinsons disease (PD) has been clearly demonstrated. It has also been documented that DA agonists may have both a positive and a negative impact on neuropsychiatric symptoms in PD patients. This paper will focus on the effects of DA agonists on depressive and cognitive symptoms of PD.
dcterms:title
Effects of dopamine agonists on neuropsychiatric symptoms of Parkinsons disease Effects of dopamine agonists on neuropsychiatric symptoms of Parkinsons disease
skos:prefLabel
Effects of dopamine agonists on neuropsychiatric symptoms of Parkinsons disease Effects of dopamine agonists on neuropsychiatric symptoms of Parkinsons disease
skos:notation
RIV/00216224:14110/10:00047011!RIV11-MSM-14110___
n4:aktivita
n15:Z
n4:aktivity
Z(MSM0021622404)
n4:cisloPeriodika
1-3
n4:dodaniDat
n9:2011
n4:domaciTvurceVysledku
n13:6033040
n4:druhVysledku
n10:J
n4:duvernostUdaju
n16:S
n4:entitaPredkladatele
n14:predkladatel
n4:idSjednocenehoVysledku
256302
n4:idVysledku
RIV/00216224:14110/10:00047011
n4:jazykVysledku
n11:eng
n4:klicovaSlova
Dopamine agonists; Parkinsons disease; Depression; Cognitive
n4:klicoveSlovo
n5:Depression n5:Cognitive n5:Dopamine%20agonists n5:Parkinsons%20disease
n4:kodStatuVydavatele
CH - Švýcarská konfederace
n4:kontrolniKodProRIV
[4D3F0DCBDA89]
n4:nazevZdroje
Neurodegenerative Diseases
n4:obor
n12:FH
n4:pocetDomacichTvurcuVysledku
1
n4:pocetTvurcuVysledku
1
n4:rokUplatneniVysledku
n9:2010
n4:svazekPeriodika
7
n4:tvurceVysledku
Rektorová, Irena
n4:wos
00027673920
n4:zamer
n6:MSM0021622404
s:issn
1660-2854
s:numberOfPages
4
n7:organizacniJednotka
14110